Inactive Instrument
CannaVEST Corp Stock OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-03 | CV Sciences, Inc. - Shareholder/Analyst Call | |
| 05-15 | CV Sciences, Inc., Q1 2026 Earnings Call, May 14, 2026 |
| Market Cap | 4.04M 3.54M 3.29M 3.02M 5.69M 390M 5.77M 39.14M 15.32M 191M 15.16M 14.83M 659M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.76M 5.04M 4.68M 4.3M 8.11M 555M 8.23M 55.78M 21.83M 272M 21.61M 21.14M 939M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
92.21% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.05% | +0.55% | +49.79% | +153.20% | 1,048B | ||
| +2.00% | +3.49% | +52.22% | +49.42% | 603B | ||
| -1.09% | +3.76% | +35.37% | +76.91% | 452B | ||
| -0.42% | +1.65% | +30.05% | +21.05% | 327B | ||
| -0.16% | +2.39% | +36.91% | +37.33% | 283B | ||
| +1.68% | +2.73% | +24.14% | +17.94% | 259B | ||
| -1.40% | -0.06% | -22.24% | -42.39% | 219B | ||
| -0.05% | +2.16% | +19.75% | +55.49% | 198B | ||
| +0.05% | -1.03% | +18.31% | +67.83% | 162B | ||
| Average | -0.00% | +1.74% | +27.14% | +48.53% | 394.63B | |
| Weighted average by Cap. | -0.03% | +1.69% | +36.11% | +73.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.76M 12.77M 11.74M 22.12M 1.52B 22.45M 152M 59.56M 742M 58.95M 57.68M 2.56B | 13.79M 12.08M 11.22M 10.31M 19.42M 1.33B 19.71M 134M 52.3M 651M 51.76M 50.65M 2.25B |
| Net income | -2.39M -2.1M -1.95M -1.79M -3.37M -231M -3.42M -23.2M -9.08M -113M -8.99M -8.79M -390M | -958K -839K -779K -716K -1.35M -92.44M -1.37M -9.28M -3.63M -45.23M -3.6M -3.52M -156M |
| Net Debt | 325K 285K 264K 243K 458K 31.36M 464K 3.15M 1.23M 15.35M 1.22M 1.19M 53.01M | 1.72M 1.51M 1.4M 1.28M 2.42M 166M 2.46M 16.65M 6.52M 81.12M 6.45M 6.31M 280M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions

















